產(chǎn)品搜索
相關(guān)文章
- 甲基丙二酸血癥(MMA)標(biāo)準(zhǔn)品上新
- 【產(chǎn)品推介】TERT診斷標(biāo)準(zhǔn)品
- 你知道ATCC細(xì)胞如何解凍嗎?
- 有關(guān)腫瘤細(xì)胞的基因突變研究講解
- BCMA靶點(diǎn)藥物細(xì)胞篩選模型
- CD47/PD-(L)1 雙靶點(diǎn)細(xì)胞篩選模型簡(jiǎn)介
- 從“腫瘤免疫療法”發(fā)展,看“單抗、CAR-T”任重而道遠(yuǎn)!
- 子宮內(nèi)膜癌精準(zhǔn)分子分型標(biāo)準(zhǔn)品,助力POLE基因檢測(cè)
- 耐藥ATCC細(xì)胞株如何構(gòu)建看完就會(huì)知道
- 腫瘤細(xì)胞的信息系統(tǒng)的改變特征大揭秘
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73287BCR-ABL1 Y253H/BaF3激酶細(xì)胞株

- 詳細(xì)內(nèi)容
CBP73287 | |
I. Introduction | |
Cell Line Name: | BCR-ABL1 [Y253H]/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes. | |
III. Representative Data | |
1. WB of BCR-ABL1 [Y253H]/BaF3 | |
2.Sanger of BCR-ABL1 [Y253H]/BaF3 Figure 2. BCR-ABL1 Y253H Figure 3. BCR-ABL1 [Y253H]/BaF3 Fusion | |
3. Anti-proliferation assay Figure 4. CTG Proliferation Assay of BaF3 BCR-ABL1 Y253H Cells (C1). | |